A detailed history of Kingsview Wealth Management, LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 31,062 shares of PMN stock, worth $13,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,062
Holding current value
$13,046
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$0.47 - $0.75 $14,599 - $23,296
31,062 New
31,062 $14,000
Q4 2023

Feb 08, 2024

BUY
$0.97 - $2.0 $10,767 - $22,200
11,100 New
11,100 $12,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.